loadpatents
Patent applications and USPTO patent grants for Bachand; Carol.The latest application filed is for "hepatitis c virus inhibitors".
Patent | Date |
---|---|
Hepatitis C virus inhibitors Grant 9,758,487 - Bachand , et al. September 12, 2 | 2017-09-12 |
Hepatitis C Virus Inhibitors App 20160311778 - Bachand; Carol ;   et al. | 2016-10-27 |
Hepatitis C virus inhibitors Grant 9,227,961 - Bachand , et al. January 5, 2 | 2016-01-05 |
Hepatitis C virus inhibitors Grant 9,018,390 - Bachand , et al. April 28, 2 | 2015-04-28 |
Hepatitis C Virus Inhibitors App 20150011754 - Bachand; Carol ;   et al. | 2015-01-08 |
Hepatitis C virus inhibitors Grant 8,846,023 - Bachand , et al. September 30, 2 | 2014-09-30 |
Hepatitis C virus inhibitors Grant 8,642,025 - Bachand , et al. February 4, 2 | 2014-02-04 |
Hepatitis C Virus Inhibitors App 20140018389 - Lavoie; Rico ;   et al. | 2014-01-16 |
Hepatitis C Virus Inhibitors App 20140017195 - Bachand; Carol ;   et al. | 2014-01-16 |
Hepatitis C virus inhibitors Grant 8,574,563 - Bachand , et al. November 5, 2 | 2013-11-05 |
Hepatitis C Virus Inhibitors App 20130280211 - Bachand; Carol ;   et al. | 2013-10-24 |
Hepatitis C virus inhibitors Grant 8,492,553 - Bachand , et al. July 23, 2 | 2013-07-23 |
Hepatitis C Virus Inhibitors App 20130034520 - Bachand; Carol ;   et al. | 2013-02-07 |
Hepatitis C Virus Inhibitors App 20130012540 - Lavoie; Rico ;   et al. | 2013-01-10 |
Hepatitis C Virus Inhibitors App 20130004457 - Bachand; Carol ;   et al. | 2013-01-03 |
Hepatitis C Virus Inhibitors App 20120328570 - Bachand; Carol ;   et al. | 2012-12-27 |
Hepatitis C virus inhibitors Grant 8,303,944 - Bachand , et al. November 6, 2 | 2012-11-06 |
Hepatitis C virus inhibitors Grant 8,288,562 - Bachand , et al. October 16, 2 | 2012-10-16 |
Hepatitis C virus inhibitors Grant 8,147,818 - Bachand , et al. April 3, 2 | 2012-04-03 |
Hepatitis C virus inhibitors Grant 8,143,414 - Lavoie , et al. March 27, 2 | 2012-03-27 |
Hepatitis C virus inhibitors Grant 8,093,243 - Bachand , et al. January 10, 2 | 2012-01-10 |
Hepatitis C Virus Inhibitors App 20110281910 - Lavoie; Rico ;   et al. | 2011-11-17 |
Hepatitis C Virus Inhibitors App 20110098327 - Lavoie; Rico ;   et al. | 2011-04-28 |
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides Grant 7,915,283 - Wang , et al. March 29, 2 | 2011-03-29 |
Hepatitis C Virus Inhibitors App 20100233120 - Bachand; Carol ;   et al. | 2010-09-16 |
Hepatitis C virus inhibitors Grant 7,759,495 - Bachand , et al. July 20, 2 | 2010-07-20 |
Hepatitis C virus inhibitors Grant 7,745,636 - Bachand , et al. June 29, 2 | 2010-06-29 |
Hepatitis C virus inhibitors Grant 7,741,347 - Bachand , et al. June 22, 2 | 2010-06-22 |
Hepatitis C virus inhibitors Grant 7,704,992 - Bachand , et al. April 27, 2 | 2010-04-27 |
Hepatitis C virus inhibitors Grant 7,659,270 - Bachand , et al. February 9, 2 | 2010-02-09 |
Hepatitis C Virus Inhibitors App 20090233925 - Bachand; Carol ;   et al. | 2009-09-17 |
Hepatitis C Virus Inhibitors App 20090202478 - Bachand; Carol ;   et al. | 2009-08-13 |
Hepatitis C Virus Inhibitors App 20090202483 - Bachand; Carol ;   et al. | 2009-08-13 |
Hepatitis C Virus Inhibitors App 20090068140 - Bachand; Carol ;   et al. | 2009-03-12 |
4-Squarylpiperazine derivatives as antiviral agents Grant 7,501,419 - Bachand , et al. March 10, 2 | 2009-03-10 |
Hepatitis C Virus Inhibitors App 20080311075 - Bachand; Carol ;   et al. | 2008-12-18 |
Hepatitis C Virus Inhibitors App 20080299075 - Bachand; Carol ;   et al. | 2008-12-04 |
Indole, Azaindole And Related Heterocyclic 4-alkenyl Piperidine Amides App 20080188481 - Wang; Tao ;   et al. | 2008-08-07 |
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides Grant 7,348,337 - Wang , et al. March 25, 2 | 2008-03-25 |
Hepatitis C Virus Inhibitors App 20080050336 - Bachand; Carol ;   et al. | 2008-02-28 |
Hepatitis C Virus Inhibitors App 20080044380 - Bachand; Carol ;   et al. | 2008-02-21 |
Hepatitis C Virus Inhibitors App 20080044379 - Bachand; Carol ;   et al. | 2008-02-21 |
4-Squarylpiperazine Derivatives as Antiviral Agents App 20070249624 - Bachand; Carol ;   et al. | 2007-10-25 |
Topoisomerase inhibitors Grant 7,138,377 - Ruediger , et al. November 21, 2 | 2006-11-21 |
Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles Grant 6,855,698 - Ruediger , et al. February 15, 2 | 2005-02-15 |
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides App 20040186292 - Wang, Tao ;   et al. | 2004-09-23 |
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides App 20040063744 - Wang, Tao ;   et al. | 2004-04-01 |
Topoisomerase inhibitors Grant 6,677,450 - Saulnier , et al. January 13, 2 | 2004-01-13 |
Tumor proliferation inhibitors Grant 6,653,290 - Ruediger , et al. November 25, 2 | 2003-11-25 |
Topoisomerase inhibitors App 20030203860 - Ruediger, Edward H. ;   et al. | 2003-10-30 |
Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles App 20030083271 - Ruediger, Edward H. ;   et al. | 2003-05-01 |
Topoisomerase inhibitors App 20020107237 - Saulnier, Mark G. ;   et al. | 2002-08-08 |
Tumor proliferation inhibitors App 20020068705 - Ruediger, Edward H. ;   et al. | 2002-06-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.